Botox Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Mexico, Brazil, Germany, Japan - Size and Forecast 2024-2028

Published: Jan 2024 Pages: 154 SKU: IRTNTR71048

Botox Market Size 2024-2028 

The botox market size is forecast to increase by USD 4.58 billion at a CAGR of 9.66% between 2023 and 2028.

  • The market is experiencing significant growth due to the increasing applications of Botox in cosmetic and therapeutic procedures. Medical aesthetics are gaining increasing importance in the healthcare industry, leading to a growth in demand for Botox. However, the high cost of Botox procedures remains a challenge for some consumers. This trend is expected to continue as more people seek to improve their appearance and address various health conditions using Botox.
  • The market is poised for continued growth, with innovations in technology and new applications driving expansion. Companies are focusing on developing more cost-effective solutions to meet the needs of a wider customer base. Overall, the market presents significant opportunities for growth in the North American region, particularly in the United States, where the demand for cosmetic procedures is high.

What will be the Size of the Market During the Forecast Period?

 Request Free Sample

  • The market has experienced significant growth in recent years, driven by the increasing demand for non-surgical solutions in medical aesthetics and health & wellness. This market segment caters to various consumer needs, including anti-aging treatments, headache relief, and pain management. Botox, a neuromuscular blocking agent, has become a popular choice for wrinkle reduction and facial rejuvenation. Its ability to temporarily paralyze muscles has made it a go-to solution for forehead wrinkles, crows feet, and other signs of aging. Furthermore, Botox injections are used for various medical conditions, such as neurological disorders and hyperhidrosis.
  • Additionally, the market for Botox and other cosmetic injectables is vast and diverse, encompassing beauty clinics, cosmetic doctors, medical spas, dermatology clinics, and wellness centers. These establishments offer a range of aesthetic treatments, including dermal fillers, brow lifts, and skin tightening, to cater to the evolving needs of consumers. Moreover, the market for Botox and other injectable treatments is not limited to anti-aging applications. It also includes the use of Botox for pain management, such as migraine prevention and headache relief. Botox injections have been proven effective in reducing the frequency and severity of migraines, making it a valuable treatment option for those suffering from this debilitating condition.
  • Similarly, the demand for Botox and other non-surgical treatments is fueled by several factors. First, consumers are increasingly seeking non-invasive solutions to address their health and wellness concerns. Second, the stigma surrounding cosmetic procedures is fading, with more people open to exploring various options to enhance their appearance and improve their quality of life. The market for Botox and other injectable treatments is expected to continue growing, driven by advancements in technology and the increasing acceptance of these treatments as safe and effective solutions. Furthermore, the growing trend towards holistic treatments and natural remedies has led to the development of alternative therapies, such as neurotoxin therapy and scar treatment, which offer similar benefits to Botox without the use of synthetic ingredients.
  • In conclusion, the market is a thriving industry that caters to a wide range of consumer needs in medical aesthetics and health & wellness. With its ability to provide temporary relief from various conditions and enhance physical appearance, Botox and other injectable treatments are becoming increasingly popular options for those seeking non-surgical solutions. The market is expected to continue growing, driven by advancements in technology and the increasing acceptance of these treatments as safe and effective solutions.

How is this market segmented and which is the largest segment?

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD billion" for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

  • Application
    • Aesthetic
    • Medical
  • End-user
    • Hospitals
    • Dermatology clinics
    • Others
  • Geography
    • North America
      • Mexico
      • US
    • Europe
      • Germany
    • Asia
      • Japan
    • Rest of World (ROW)

By Application Insights

  • The aesthetic segment is estimated to witness significant growth during the forecast period.

The market, driven by the aesthetic segment, is poised for consistent expansion over the coming years. The rise in this market can be attributed to the growing awareness of cosmetic procedures and the continuous advancements in the aesthetic domain. Reports from leading medical aesthetic organizations, such as the International Society of Aesthetic Plastic Surgery (ISAPS) and the American Society for Aesthetic Plastic Surgery (ASAPS), indicate a global upsurge in the number of aesthetic procedures being performed.

Additionally, key countries contributing significantly to this trend include the US, Brazil, Japan, Italy, Mexico, Russia, India, Turkey, Germany, and France, which collectively account for over half of the global volume of aesthetic procedures. Clostridium botulinum, the bacterium responsible for producing Botox, is increasingly being utilized to address fine lines, wrinkles, and other signs of aging. Hospitals and clinics are the primary end users in the market, catering to the increasing demand for these cosmetic treatments.

Get a glance at the market report of share of various segments Request Free Sample

The aesthetic segment was valued at USD 4.22 billion in 2018 and showed a gradual increase during the forecast period.

Regional Analysis

  • North America is estimated to contribute 51% to the growth of the global market during the forecast period.

Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

For more insights on the market share of various regions Request Free Sample

The market in North America experienced significant growth in 2023, with the United States being the primary contributor to the region's revenue. Factors driving this market expansion include technological innovations, rising awareness of cosmetic procedures, increasing preference for minimally invasive treatments, and the growing population of older adults. Individuals in this age group are more susceptible to aging signs, such as wrinkles, scars, and acne. In response, some are turning to cosmetic interventions, including Botox injections, to improve their appearance. Neurotoxins, such as Botox, are increasingly used to address various health conditions beyond cosmetic applications. For instance, they are effective in treating conditions like spasticity resulting from primary neurological illnesses.

Furthermore, Botox injections are utilized to alleviate symptoms of tension-type headaches and overactive bladder. The market for Botox injections is not limited to cosmetic applications. Neurotoxins are also used to treat medical conditions like spasticity and tension-type headaches. In the US, the number of individuals suffering from these conditions is substantial. For instance, according to the National Institute of Neurological Disorders and Stroke, approximately 12% of the US population experiences tension-type headaches at least once per year. Filler treatments, such as Botox, are increasingly popular due to their non-invasive nature and quick results. They offer an alternative to more invasive surgical procedures, making them an attractive option for those seeking to address aging signs or medical conditions.

In conclusion, the market in North America, particularly in the US, is poised for continued growth due to the increasing demand for minimally invasive treatments, an aging population, and the expanding applications of Botox beyond cosmetic uses.

Market Dynamics

Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

What are the key market drivers leading to the rise in adoption of Botox Market?

Increasing applications of Botox in cosmetic and therapeutic procedures is the key driver of the market.

  • Botox, a neurotoxin derived from the bacterium Clostridium botulinum, has gained significant popularity in both therapeutic and cosmetic applications. First FDA-approved in 1989 for eye muscle disorders, Botox now holds approvals for 11 therapeutic indications, including chronic migraine, overactive bladder, spasticity, cervical dystonia, and severe sweating (axillary hyperhidrosis). In the realm of cosmetic procedures, Botox injections have become a go-to solution for addressing fine lines, wrinkles, and skin abnormalities, particularly around the forehead, glabellar lines, perioral areas, and masseter brown lines. Neurological illnesses, such as primary neurological illnesses and dystonia, are also treated with Botox injections to manage symptoms like cervical rigidity and tension-type headaches.
  • Additionally, botox's therapeutic uses extend to non-invasive treatments for conditions like hyperhidrosis and detrusor hyperactivity. Dermatological clinics, hospitals, med spas, and skincare clinics offer Botox treatments for cosmetic and therapeutic purposes. Botulinum toxin, the neurotoxic protein in Botox, works by blocking the release of acetylcholine, thereby relaxing muscles and reducing nerve signals. Cosmetic uses of Botox include microbotox, mesotherapy, skin peels, and dermaplaning, providing natural-looking results for individuals seeking to combat the aging process. Other neurotoxins, like Dysport, Xeomin, and Jeuveau, serve similar purposes. Botox's versatility and effectiveness have solidified its position in the medical aesthetics market.

What are the market trends shaping the Botox Market?

The growing importance of medical aesthetics is the upcoming trend in the market.

  • The market is experiencing significant growth due to the increasing popularity of neurotoxin injections for various medical and cosmetic applications. Neurotoxins, such as Botox, Dysport, and Xeomin, are commonly used to treat conditions like spasticity in primary neurological illnesses, cervical dystonia, and dystonia. In the realm of cosmetic treatments, neurotoxins are widely used to address issues like forehead lines, frown lines, and perioral lines, providing natural-looking results. Botox injections are also utilized for therapeutic purposes, such as treating tension-type headaches, migraines, overactive bladder, and hyperhidrosis. The use of neurotoxins for medical aesthetics is a growing trend, with an annual growth rate of 10%-12%, resulting in approximately 10-12 million procedures performed worldwide each year.
  • Moreover, dermatological clinics, hospitals, med spas, and skincare clinics are the primary end-users of these treatments. The development of new drug formulations and the expansion of cosmetic applications for neurotoxins, such as microbotox and cosmetic use for square jaw, masseter brown lines, and glabellar lines, are driving the growth of the market. The use of botulinum toxin for cosmetic procedures, like skin peels, derma planning, and mesotherapy, is also gaining popularity. The neurotoxic protein, produced by the bacteria Clostridium botulinum, is used to relax muscles and inhibit acetylcholine release, making it an effective solution for a range of medical and cosmetic concerns.
  • In conclusion, gender does not limit the market, as both females and males seek these treatments. Social media influencers and the increasing acceptance of cosmetic procedures have contributed to the growing demand for these treatments. The medical aesthetics market is expected to continue its growth trajectory, offering long-lasting results for various skin abnormalities and aging process concerns.

What challenges does Botox Market face during the growth?

The high cost of botox procedures is a key challenge affecting the market growth.

  • The market, driven by the use of botulinum toxin for neurotoxic applications, continues to expand, with key indications including spasticity due to primary neurological illnesses, tension-type headaches, and dystonia. However, the high cost of these procedures, which includes expenses for screening tests, aesthetic product costs, recurrence procedures, and consultation fees, remains a significant barrier to entry for many consumers, particularly in developing countries. The global average selling price of botulinum toxin ranges from USD 300-USD 500. The absence of reimbursement policies in developed countries, such as the US, the UK, Germany, France, and Japan, further exacerbates the affordability issue. In addition to these applications, botulinum toxin is also used for cosmetic purposes, such as reducing fine lines, wrinkles, and hyperhidrosis, as well as for treating overactive bladder and detrusor hyperactivity.
  • Other neurotoxins, such as Dysport, Xeomin, and Jeuveau, are also gaining popularity. The market for botulinum toxin is diverse, with end users including hospitals, clinics, med spas, and dermatological clinics. The use of botulinum toxin for cosmetic applications is increasingly popular among females, with social media influencers promoting natural-looking results. The aging process and various skin abnormalities, such as perioral lines, masseter brown lines, and glabellar lines, are common indications for cosmetic botulinum toxin treatments.
  • In conclusion, the market for botulinum toxin is expected to grow as new therapeutic applications are developed, and as the drug development pipeline for new indications progresses. Microbotox and other minimally invasive treatments, such as nerve signals blocking through micro botulinum toxin injections, are also gaining popularity. Overall, the market for botulinum toxin is expected to continue to grow, driven by increasing demand for non-invasive treatments and the expanding range of applications for this versatile drug.

Exclusive Customer Landscape

The market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.

 Customer Landscape

Key Companies & Market Insights

Companies are implementing various strategies, such as strategic alliances, market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.

The market research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:

  • AbbVie Inc.
  • Bausch Health Companies Inc.
  • BTXA
  • Candela Corp.
  • Daewoong Bio Inc.
  • Eisai Co. Ltd.
  • Evolus Inc
  • FASTOX Pharma
  • Galderma SA
  • Hugel Inc
  • Huons Global
  • Ipsen Pharma
  • MedyTox Co. Ltd.
  • Merz Pharma GmbH and Co KGaA
  • NEXUS LIFECARE PVT. LTD.
  • Object Pharma Inc.
  • Revance Therapeutics Inc.
  • SciVision Biotech Inc.
  • Suneva Medical
  • USWM LLC

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Research Analyst Overview

Neurotoxins, specifically botulinum toxin, have gained significant attention in both the beauty and therapeutic markets due to their effectiveness in addressing various concerns. These neurotoxins work by inhibiting the release of acetylcholine, a neurotransmitter responsible for muscle contractions. This property makes neurotoxins an ideal solution for treating a range of conditions, from cosmetic applications to therapeutic interventions. The primary applications of neurotoxins include the treatment of fine lines and wrinkles, particularly in the preauricular lines, forehead lines, and perioral areas. Neurotoxins have also shown promising results in managing conditions such as spasticity, primary neurological illnesses, and hyperhidrosis.

In the therapeutic sphere, neurotoxins are used to treat conditions like cervical dystonia, dystonia, overactive bladder, and tension-type headaches. Neurotoxins have become increasingly popular as non-invasive treatments, offering a more convenient alternative to cosmetic surgery. These treatments provide natural-looking results, making them a preferred choice for individuals seeking to improve their appearance without undergoing invasive procedures. Botox, Dysport, Xeomin, and other neurotoxins have found extensive use in the beauty industry for facial aesthetics. These treatments can help relax muscles, reducing the appearance of wrinkles and fine lines, and improving the overall appearance of the skin. Neurotoxins are also used in combination with other cosmetic procedures, such as dermabrasion, microbotox, skin peels, and mesotherapy, to enhance the overall effectiveness of the treatment.

Moreover, the use of neurotoxins is not limited to females; they have gained popularity among males as well, particularly for addressing concerns related to masseter brown lines, square jaw, and other cosmetic applications. Neurotoxins are administered through injections, making them easily accessible at dermatological clinics, hospitals, med spas, and other healthcare facilities. The market for neurotoxins is expected to grow significantly due to the increasing acceptance of minimally invasive treatments and the rising influence of social media influencers promoting these procedures. The therapeutic applications of neurotoxins are also expected to drive market growth, as more individuals seek effective treatments for conditions like chronic migraine, lazy eye, and detrusor hyperactivity.

In conclusion, the development of new neurotoxins and formulations, such as micro botulinum toxin, is expected to further expand the market. However, concerns regarding the safety and potential side effects of neurotoxins, as well as the risk of bacterial contamination from Clostridium botulinum, may limit market growth. In conclusion, the neurotoxin market is poised for significant growth, driven by the increasing popularity of non-invasive cosmetic treatments and the expanding range of therapeutic applications. The market dynamics, including the growing acceptance of neurotoxins, the development of new formulations, and the potential risks and challenges, are crucial factors shaping the future of the neurotoxin market.

Market Scope

Report Coverage

Details

Page number

154

Base year

2023

Historic period

2018-2022

Forecast period

2024-2028

Growth momentum & CAGR

Accelerate at a CAGR of 9.66%

Market growth 2024-2028

USD 4.58 billion

Market structure

Fragmented

YoY growth 2023-2024(%)

9.22

Key countries

US, Mexico, Brazil, Germany, and Japan

Competitive landscape

Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks

Request Free Sample

What are the Key Data Covered in this Market Research and Growth Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the market growth and forecasting between 2024 and 2028
  • Precise estimation of the size of the market  and its contribution of the market in focus to the parent market
  • Accurate predictions about upcoming market growth and trends and changes in consumer behaviour
  • Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
  • Thorough analysis of the market's competitive landscape and detailed information about companies
  • Comprehensive analysis of factors that will challenge the growth of market companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Application
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2023
    • 3.4 Market outlook: Forecast for 2023-2028
      • Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

    4 Historic Market Size

    • 4.1 Global botox market 2018 - 2022
      • Exhibit 18: Historic Market Size – Data Table on global botox market 2018 - 2022 ($ billion)
    • 4.2 Application Segment Analysis 2018 - 2022
      • Exhibit 19: Historic Market Size – Application Segment 2018 - 2022 ($ billion)
    • 4.3 End-user Segment Analysis 2018 - 2022
      • Exhibit 20: Historic Market Size – End-user Segment 2018 - 2022 ($ billion)
    • 4.4 Geography Segment Analysis 2018 - 2022
      • Exhibit 21: Historic Market Size – Geography Segment 2018 - 2022 ($ billion)
    • 4.5 Country Segment Analysis 2018 - 2022
      • Exhibit 22: Historic Market Size – Country Segment 2018 - 2022 ($ billion)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
    • 5.2 Bargaining power of buyers
      • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
    • 5.3 Bargaining power of suppliers
      • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
    • 5.4 Threat of new entrants
      • Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028
    • 5.5 Threat of substitutes
      • Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028
    • 5.6 Threat of rivalry
      • Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028
    • 5.7 Market condition
      • Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

    6 Market Segmentation by Application

    • 6.1 Market segments
      • Exhibit 30: Chart on Application - Market share 2023-2028 (%)
      • Exhibit 31: Data Table on Application - Market share 2023-2028 (%)
    • 6.2 Comparison by Application
      • Exhibit 32: Chart on Comparison by Application
      • Exhibit 33: Data Table on Comparison by Application
    • 6.3 Aesthetic - Market size and forecast 2023-2028
      • Exhibit 34: Chart on Aesthetic - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 35: Data Table on Aesthetic - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 36: Chart on Aesthetic - Year-over-year growth 2023-2028 (%)
      • Exhibit 37: Data Table on Aesthetic - Year-over-year growth 2023-2028 (%)
    • 6.4 Medical - Market size and forecast 2023-2028
      • Exhibit 38: Chart on Medical - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 39: Data Table on Medical - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 40: Chart on Medical - Year-over-year growth 2023-2028 (%)
      • Exhibit 41: Data Table on Medical - Year-over-year growth 2023-2028 (%)
    • 6.5 Market opportunity by Application
      • Exhibit 42: Market opportunity by Application ($ billion)
      • Exhibit 43: Data Table on Market opportunity by Application ($ billion)

    7 Market Segmentation by End-user

    • 7.1 Market segments
      • Exhibit 44: Chart on End-user - Market share 2023-2028 (%)
      • Exhibit 45: Data Table on End-user - Market share 2023-2028 (%)
    • 7.2 Comparison by End-user
      • Exhibit 46: Chart on Comparison by End-user
      • Exhibit 47: Data Table on Comparison by End-user
    • 7.3 Hospitals - Market size and forecast 2023-2028
      • Exhibit 48: Chart on Hospitals - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 49: Data Table on Hospitals - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 50: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
      • Exhibit 51: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
    • 7.4 Dermatology clinics - Market size and forecast 2023-2028
      • Exhibit 52: Chart on Dermatology clinics - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 53: Data Table on Dermatology clinics - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 54: Chart on Dermatology clinics - Year-over-year growth 2023-2028 (%)
      • Exhibit 55: Data Table on Dermatology clinics - Year-over-year growth 2023-2028 (%)
    • 7.5 Others - Market size and forecast 2023-2028
      • Exhibit 56: Chart on Others - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 57: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 58: Chart on Others - Year-over-year growth 2023-2028 (%)
      • Exhibit 59: Data Table on Others - Year-over-year growth 2023-2028 (%)
    • 7.6 Market opportunity by End-user
      • Exhibit 60: Market opportunity by End-user ($ billion)
      • Exhibit 61: Data Table on Market opportunity by End-user ($ billion)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Exhibit 63: Chart on Market share by geography 2023-2028 (%)
      • Exhibit 64: Data Table on Market share by geography 2023-2028 (%)
    • 9.2 Geographic comparison
      • Exhibit 65: Chart on Geographic comparison
      • Exhibit 66: Data Table on Geographic comparison
    • 9.3 North America - Market size and forecast 2023-2028
      • Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
      • Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
    • 9.4 Europe - Market size and forecast 2023-2028
      • Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
      • Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
    • 9.5 Asia - Market size and forecast 2023-2028
      • Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
      • Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
    • 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
      • Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
      • Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
    • 9.7 US - Market size and forecast 2023-2028
      • Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
      • Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
    • 9.8 Brazil - Market size and forecast 2023-2028
      • Exhibit 87: Chart on Brazil - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 88: Data Table on Brazil - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 89: Chart on Brazil - Year-over-year growth 2023-2028 (%)
      • Exhibit 90: Data Table on Brazil - Year-over-year growth 2023-2028 (%)
    • 9.9 Japan - Market size and forecast 2023-2028
      • Exhibit 91: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 92: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 93: Chart on Japan - Year-over-year growth 2023-2028 (%)
      • Exhibit 94: Data Table on Japan - Year-over-year growth 2023-2028 (%)
    • 9.10 Mexico - Market size and forecast 2023-2028
      • Exhibit 95: Chart on Mexico - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 96: Data Table on Mexico - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 97: Chart on Mexico - Year-over-year growth 2023-2028 (%)
      • Exhibit 98: Data Table on Mexico - Year-over-year growth 2023-2028 (%)
    • 9.11 Germany - Market size and forecast 2023-2028
      • Exhibit 99: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 100: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
      • Exhibit 101: Chart on Germany - Year-over-year growth 2023-2028 (%)
      • Exhibit 102: Data Table on Germany - Year-over-year growth 2023-2028 (%)
    • 9.12 Market opportunity by geography
      • Exhibit 103: Market opportunity by geography ($ billion)
      • Exhibit 104: Data Tables on Market opportunity by geography ($ billion)

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 105: Impact of drivers and challenges in 2023 and 2028
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 107: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 108: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 109: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 110: Matrix on vendor position and classification
            • 12.3 AbbVie Inc.
              • Exhibit 111: AbbVie Inc. - Overview
              • Exhibit 112: AbbVie Inc. - Product / Service
              • Exhibit 113: AbbVie Inc. - Key news
              • Exhibit 114: AbbVie Inc. - Key offerings
            • 12.4 BTXA
              • Exhibit 115: BTXA - Overview
              • Exhibit 116: BTXA - Product / Service
              • Exhibit 117: BTXA - Key offerings
            • 12.5 Daewoong Bio Inc.
              • Exhibit 118: Daewoong Bio Inc. - Overview
              • Exhibit 119: Daewoong Bio Inc. - Product / Service
              • Exhibit 120: Daewoong Bio Inc. - Key offerings
            • 12.6 Evolus Inc
              • Exhibit 121: Evolus Inc - Overview
              • Exhibit 122: Evolus Inc - Product / Service
              • Exhibit 123: Evolus Inc - Key offerings
            • 12.7 FASTOX Pharma
              • Exhibit 124: FASTOX Pharma - Overview
              • Exhibit 125: FASTOX Pharma - Product / Service
              • Exhibit 126: FASTOX Pharma - Key offerings
            • 12.8 Galderma SA
              • Exhibit 127: Galderma SA - Overview
              • Exhibit 128: Galderma SA - Product / Service
              • Exhibit 129: Galderma SA - Key news
              • Exhibit 130: Galderma SA - Key offerings
            • 12.9 Hugel Inc
              • Exhibit 131: Hugel Inc - Overview
              • Exhibit 132: Hugel Inc - Product / Service
              • Exhibit 133: Hugel Inc - Key offerings
            • 12.10 Huons Global
              • Exhibit 134: Huons Global - Overview
              • Exhibit 135: Huons Global - Product / Service
              • Exhibit 136: Huons Global - Key offerings
            • 12.11 Ipsen Pharma
              • Exhibit 137: Ipsen Pharma - Overview
              • Exhibit 138: Ipsen Pharma - Business segments
              • Exhibit 139: Ipsen Pharma - Key offerings
              • Exhibit 140: Ipsen Pharma - Segment focus
            • 12.12 MedyTox Co. Ltd.
              • Exhibit 141: MedyTox Co. Ltd. - Overview
              • Exhibit 142: MedyTox Co. Ltd. - Product / Service
              • Exhibit 143: MedyTox Co. Ltd. - Key offerings
            • 12.13 Merz Pharma GmbH and Co KGaA
              • Exhibit 144: Merz Pharma GmbH and Co KGaA - Overview
              • Exhibit 145: Merz Pharma GmbH and Co KGaA - Product / Service
              • Exhibit 146: Merz Pharma GmbH and Co KGaA - Key offerings
            • 12.14 NEXUS LIFECARE PVT. LTD.
              • Exhibit 147: NEXUS LIFECARE PVT. LTD. - Overview
              • Exhibit 148: NEXUS LIFECARE PVT. LTD. - Product / Service
              • Exhibit 149: NEXUS LIFECARE PVT. LTD. - Key offerings
            • 12.15 Object Pharma Inc.
              • Exhibit 150: Object Pharma Inc. - Overview
              • Exhibit 151: Object Pharma Inc. - Product / Service
              • Exhibit 152: Object Pharma Inc. - Key offerings
            • 12.16 Revance Therapeutics Inc.
              • Exhibit 153: Revance Therapeutics Inc. - Overview
              • Exhibit 154: Revance Therapeutics Inc. - Product / Service
              • Exhibit 155: Revance Therapeutics Inc. - Key offerings
            • 12.17 SciVision Biotech Inc.
              • Exhibit 156: SciVision Biotech Inc. - Overview
              • Exhibit 157: SciVision Biotech Inc. - Product / Service
              • Exhibit 158: SciVision Biotech Inc. - Key offerings

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 159: Inclusions checklist
                • Exhibit 160: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 161: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 162: Research methodology
                • Exhibit 163: Validation techniques employed for market sizing
                • Exhibit 164: Information sources
              • 13.5 List of abbreviations
                • Exhibit 165: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              PURCHASE FULL REPORT OF

              botox market market

              Key Questions Answered

              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?

              Why should you prefer Technavio's market insights report?

              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis